Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer
Status:
Terminated
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Currently there is no one standard of care for older patients with metastatic colorectal
cancer. The study will examine the tumor response to capecitabine, oxaliplatin, plus
bevacizumab. The study will also gather information on the usefulness and side effects of
this treatment combination.